Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
.15 to .20
Until Partnership is announced
Then .95 to 1.99
till results
Then 2.50 to 4.99
Just having a little fun !
NCHsoftware.com Software
Its big Pharma hacking the presentation!
fyi -- Im making my own copy of the presentation ! Just in case
Live now
Sounds like a large crowd in the backround
I'm making my own copy in case they edit the presentation later
The picture is up for the presentation
who are the two guys frozen in the picture.
Hope we don't have some tech trouble
With about 20-25 minutest left . Here are the numbers
4,921,887 buys
1,770,776 Sells
353,339 Don't know LOL They must be trying to decide ! LOL
8 is great but the fight has just begun!
Who will the winner be? (Maybe they will over pay)
Whats left after our Spectrum is gone?
Its going to feel like a long weekend !
I wonder how the shorts feel right about now?
Trading in the 2.30 range 7.76 mil
Should we buy AT and T Just think of all those phones ringing telling people that they have to cover
Bid 0 Ask 0
Halted ! For News
FDA Approves Trial
FDA Allows Ziopharm's Brain Cancer Drug Trial
The Boston, Massachusetts-based biopharmaceutical company will now proceed with planning registration for the trial, which will be initiated in 2017.
The planning will finalize the protocol design options for the trial, which will include a comparative assessment of the drug against historical controls in a subset of recurrent GBM patients. Recurrence indicates return of a sign, symptom, or disease after a period of disappearance. The company will share the details of the Phase 3 trial in the near future once the discussions are finalized with clinical advisors as well as regulators.
Glioblastoma is a malignant tumor that affects the brain or spine. The cancer spreads rapidly, and leads to headache, nausea, drowsiness, blurred vision, personality changes and seizures. (See also, Tracon Tanks on Brain Cancer Drug Failure.)
A lot of drugs are being developed by different companies for treating glioblastoma. They include Northwest Biotherapeutics Inc.’s (NWBO
Northwest Biotherapeutics Inc
NWBO
0.16
-3.57%
) DCVax-L, GW Pharmaceuticals PLC’s (GWPH
GW Pharmaceuticals Shs Sponsored American Deposit Share Repr 12 Shs
GWPH
103.73
-2.15%
) combination therapy of cannabidiol and tetrahydrocannabinol, and Agenus Inc.'s (AGEN
Agenus Inc
AGEN
3.74
-1.58%
) Prophage (HSPPC-96) in combination with Merck & Co. Inc.'s (MRK
Merck & Co Inc
MRK
64.43
+0.77%
) Keytruda (pembrolizumab). (See also, GW Pharma Spikes on Cannabis Drug Success.)
Read more: FDA Allows Ziopharm Brain Cancer Drug Trial (ZIOP) | Investopedia http://www.investopedia.com/news/fda-allows-ziopharm-brain-cancer-drug-trial-ziop/#ixzz4grtbqphf
Follow us: Investopedia on Facebook
U.S. FDA approves Merck immunotherapy/chemo combo for lung cancer
Even tho many treatments are being rejected/not working it feels like we are being left behind.
It must be the lack of communications, we can still rock the medical world if results come out they way we expect. I think these last two weeks are the first two weeks in a very long time that I didn't pick up a few shares.
I believe that I have the most buy orders than anyone here. They may be smaller trades but they are powerful trades !
Sneaking up on 6 figures
Another
ZURICH (Reuters) - Roche's Tecentriq immuno-oncology drug failed a late-stage follow-up trial against advanced bladder cancer, the Swiss drugmaker said on Wednesday, raising questions about whether regulators could scale back their approval of the medicine.
Roche, the world's biggest maker of cancer drugs, had won fast-track approval last May in the United States for Tecentriq against bladder cancer but full approval hinged on further trials.
Roche said a phase III IMvigor211 study that evaluated the drug in people with locally advanced or metastatic urothelial cancer whose disease progressed during or after treatment with chemotherapy "did not meet its primary endpoint of overall survival compared to chemotherapy."
The Swiss company's shares fell nearly 2 percent.
Roche said it was sticking by Tecentriq.
May 4 (UPI) -- The U.S. Food & Drug Administration Thursday approved a new drug to treat the most common form of liver cancer, hepatocellular carcinoma.
The drug, regorafenib, is the first and only treatment approved by the FDA in more than a decade to show significant improvement in patients with hepatocellular carcinoma, or HCC.
Regorafenib was shown to extend overall survival by 10.6 months compared to 7.8 months for patients receiving a placebo, resulting in an average improvement in survival of 3.1 months and a 37 percent reduction in the risk of death in patients with HCC.
http://www.upi.com/Health_News/2017/05/04/FDA-approves-new-drug-to-treat-type-of-liver-cancer/9001493927465/
Nice to be past that earnings report!
There was no way we were going to get good news before that report!!
BUT now we are past that episode so anything goes now!
ANYTHING GOES! Bring it on !
Big Pharma may glance over to this message board once in a while and maybe not but who cares.
I enjoy going over to their message boards and ask them if they are going to be left behind by not working with DCVAX while their competitors in big Pharma make the move and work With/Combine with Northwest BIO / DCVAX.
Who is going to be left holding the bag and leave behind that multi billion dollar market share.!!!!
They will not only miss participate in that market share but they will also see their market share shrink down to nothing.
How are they going to keep all those dividends going to their shareholders. LOLOL
Oh the misery !
We just had 22 4k trades in a row!
Just stands out - games that are played !
Interesting to see only 4 orders at the bid and 4 at he ask today. How long has it been this way?
Just wondering what this means? No interest till news ?
This is the first time I'm seeing the results and conference call taking place when the market is open!
In the past the Conference Call always after the market is closed.
Stands out as a surprise in policy.
What else is going to surprise????
Fire?
You have to be crazy to be short!
This rocket is going up very slow, a few pennies at a time.
5 to 10 percentage a day
That is the way to hold your gains, not a 25% move in a day unless Revenue is associated with the move.
20 minutes into the market -- 7.5 million shares
oh yea just an average day ! LOL
Its only Tuesday Going to be exciting moving toward the 27th
100,000 shares one trade at 1.98
Acting like news soon
BREAKOUT !
Yes - colmar, how awesome that would be !
I believe they are trying to cut off the money from the company.
Also - Linda will out maneuver around them.
Everyone is living longer !
First award for a vaccine!
Alan Butler doing just fine!
We are waiting for results while other companies jumped the gun and now are back pedaling.
No adverse effects from DCVAX!
Freeze our vaccine for years!
Production capabilities increased
Lawsuits thrown out
I also think that the cost of this vaccine becomes spread out during the Vaccine process. And cost lower than some other processing.
I could dig deeper and increase this list but need to get back to work
Just received this email from google
Global Therapeutic Vaccines Market 2017 – DCVax-Brain, Oncophase, CIMAVAX, Provenge, OncoVax
http://www.albaniantimes.com/2017/04/19/global-therapeutic-vaccines-market-2017/
I think you have to pay for the article.
Yes very nice day
Market cap above $2 billion, where can it go?
I have a difficult time placing market Cap on this tech!
Thanks
Yes - I can verify at the ask
As I look back and forth - seconds
this is what I wrote down for total volumne in the last few minutes
In thousands of course
97
132
142
362
688
699
707
Another bites the dust (Don't know if already posted)
OncoMed Pharmaceuticals Inc. shares were halted in premarket trade Monday on news that the company's midstage pancreatic cancer trial had missed its primary endpoint and that Bayer AG ADR would not be using its option to license two of OncoMed's cancer drugs. OncoMed said that its demcizumab, part of a partnership with Celgene Corp. , was being tested with two chemotherapy drugs in previously untreated metastatic pancreatic cancer. The company said it will be discontinuing the clinical trial after Monday's results.
Whats going on pre-market over 2.00 and trading
Interesting - We had a small view of how the trading will take place when we finally have news to talk about. When this 8K was release the blocks started to fly into the stock and we hit the high of the day.
Every time i wrote down the volume for the day i would look back and we already traded a number of blocks which moved up the price.
Now sadly when it was realized that the 8K was just an update of older news we slowly fell back !
Hey, its Friday and it was able to get my blood moving quicker for about 45 minutes.
This is fun and your having it !
Volume is rolling in the last few minutes
WOW - That was Awesome, Our ships came charging in to save the day
The ASK (.225) had a 28150 size to it
And the next trade took place at the ask for you guess it 28150 shares at .225
Ummmm Just Coincidence? I don't think so !
Don't you think that 28150 is such a nice round number ! LOL
We are being Watched !
Ask moved up to .23 Lets see how the rest of the day goes !
MD1225 NYSE???
This message board will be able to turn into the millionaires club!
For some anyways! Wink ! Wink !
Anything is possible
Me Too Tilt
That would be right in my wheel house!
Decided to pay my taxes another way ! LOL
I'LL Wait a short time for a hit job else I'll just go forward!
Notice that 'Else' how funny just finished putting some code together !
Doc
I'm bookmarking that last post, just so I can reread it now and then.
Original for sure !
Looks like our little gem is in a better bargaining position this morning!
JD - Both strategies are good ones to follow, all depends on ones own risk one would like to take.
Even tho we aren't getting the price movement DCVAX is looking better and better .... as far as the competition , all we have to do is cross that goal line ! AND THEN BAM!
Funny - We just had a 40k go by at .245 at the ask. I'm questioning why we only have two orders at the ask at .245 one by VERT and the other by ARXS.
And yet their order don't go away and we don't move up.
On the other side of the price if these trades went by ad the bid it would adjust and orders would be adjusted. Most likely move down.
Maybe its because of the market we now reside ????
I guess we have to put up with this until we get some news....
Story doesn't change -- we news some kind of news.
I never knew a lawyer that would like to talk about situations.
Always worried about what they are saying on the record.
Doesn't matter if its a hypothetical -- This is what we have here !
So we wait! ---
Vert just went away and was replaced by ARCA They knew I was writing this - I must be hacked ! They wired me LOL
Captain
I finally understand the One last vaccine situation. They ran out of vaccine when she crossed over, only had one left !
Slow , but I come around !
Sharpie - The link still works for me, I downloaded the PDF.
If Sunday knew it was DCVAX then
We should just interview all the cross overs people to determine who was on the DCVAX and who was on the Placebo. That would change every one's speadsheets...
I'm certainly not negative on DCVAX, in fact it feels funny that I have not made a purchase for 2 weeks, (Dam Taxes) but I don't know how we could know specific's if the trial is blinded.
All patients whether they were on DCVAX or Placebo was told that they have one Vaccine left.
I'm done with this, I don't post much because there are smarter people here than me! Thanks again for the good information on this board.
It certainly kept me here ! I have so many bookmarks from this site that go way back, actually I just started a new folder so I can reference the latest !
Have a Great Day !
Door No that is not the case
What if she was on the Placebo when she crossed over, what does the nurse say to her then?
Oh you have only one Placebo shot left? Lets just throw it away?
Its Blinded correct?
I don't think so !
Captain
I realize what her face book describes, I've been following her for well over a year now, maybe 2 ! What a nice lady, I feel that listening to her speak or sing takes some of my stress right out of me. Very peaceful !
BUT I have a hard time believing that just because she stated she was on DCVAX that it was really DCVAX. (Blinded)
Now if she wasn't in the trial and received it another way that would be different story.
If Sunday was in the trial how do we know that she was receiving the DCVAX?
The trial is blinded,
When they told her she had only two vaccines left or was it one it could of been the placebo. On the Placebo they only have a number of vaccines also.
If they tell the cross overs if they were receiving DCVAX then the trial is not really a blinded trial.
All I'm asking is do we really know if Sunday was taking DCVAX or the Placebo?